Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reaffirms Neutral Rating on Black Stone Minerals with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 7, 2024
in Breaking News
0
Finance_ stocks to buy
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

On March 7, 2024, Piper Sandler analyst Mark Lear reaffirms his Neutral rating on Black Stone Minerals (NYSE: BSM) while increasing the price target from $16 to $17. Lear’s updated outlook on the company’s performance is reflected in this adjustment. It is worth mentioning that the average price target for Black Stone Minerals stands at $19.00, with projections ranging from $17.00 to $21.00. There have also been cases where the price target was revised down to $15, showcasing the diverse opinions on the company’s valuation and future potential.

BSM Stock Shows Positive Momentum with 0.32% Rise on March 7, 2024: Investors Remain Cautiously Optimistic

On March 7, 2024, BSM stock showed some positive momentum as it experienced a slight increase in its price. BSM shares closed at $15.44, marking a $0.05 increase since the market last closed, representing a 0.32% rise in the stock price.

In pre-market trading, BSM stock rose an additional $0.04, indicating that investors may have a positive outlook on the company’s performance and potential for growth.

Investors should conduct thorough research and analysis before making any investment decisions, as market conditions can change rapidly. It is essential to stay informed and updated on the latest developments that may impact stock performances.

BSM stock showed promising signs on March 7, 2024, with a steady increase in its price. Investors will be closely monitoring the stock’s performance in the coming days to see if this positive momentum continues.

BSM Stock Performance Analysis: Revenue Decline but Net Income Increases

On March 7, 2024, BSM stock showed mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year was $501.10 million, which decreased by 36.11% compared to the previous year. However, the total revenue remained flat since the last quarter at $136.38 million.

In terms of net income, BSM reported a net income of $422.55 million for the past year, which represented an 11.32% decrease compared to the previous year. On the other hand, the net income for the last quarter was $147.65 million, showing a significant increase of 137.88% since the previous quarter.

Earnings per share (EPS) for BSM stock was $1.88 for the past year, reflecting a 7.5% decrease compared to the previous year. The EPS remained flat since the last quarter at $0.65.

Overall, BSM stock showed a decline in total revenue and net income compared to the previous year. However, the company managed to increase its net income significantly since the last quarter. The EPS remained stable since the last quarter, indicating a potential stabilization in the company’s financial performance.

Tags: BSM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Renewable energy

Analyst Reiterates Overweight Rating and Increases Price Target for Chord Energy NASDAQ CHRD

Analyst Reaffirms Buy Rating and Price Target for Mayville Engineering

Pharmaceutical Markets and money

Novo Nordisks Amycretin A GameChanger in Weight Loss Treatment

Recommended

Torrid Holdings Stock

Torrid Holdings Faces Critical Earnings Test

5 months ago
Take-Two Stock

Take-Two Shares in Holding Pattern as Investors Await GTA VI Details

6 months ago
Union Pacific Stock

Union Pacific’s Future Hangs in Balance as Historic Railroad Merger Faces Critical Vote

4 months ago
Biotechnology Markets and money

BioTechnes Quarterly Earnings and Stock Performance Analysis

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Claros Mortgage Trust Secures Financial Flexibility Through Strategic Debt Overhaul

Trending

Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

by SiterGedge
February 7, 2026
0

The integration of Vigil Neuroscience into French pharmaceutical giant Sanofi has been finalized. This strategic move, which...

Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026
Potbelly Stock

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success
  • Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com